USFDA accepts for review AstraZeneca’s supplemental biologics license application for self-administration of FluMist Quadrivalent
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
hey were educated about the 7- step hand-washing technique trainings
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
Commenced operations in flood-affected Himachal Pradesh
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
Subscribe To Our Newsletter & Stay Updated